Celgene Corp Company Profile

Biologic Drugs for Celgene Corp

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Patent No.	Estimated Patent Expiration	Source
Celgene Corporation, A Bristol-myers Squibb Company	ABECMA	idecabtagene vicleucel	Injection	125736	10,214,586	2036-08-18	DrugPatentWatch analysis and company disclosures
Celgene Corporation, A Bristol-myers Squibb Company	ABECMA	idecabtagene vicleucel	Injection	125736	10,703,844	2037-12-15	DrugPatentWatch analysis and company disclosures
Celgene Corporation, A Bristol-myers Squibb Company	ABECMA	idecabtagene vicleucel	Injection	125736	11,046,758	2038-12-05	DrugPatentWatch analysis and company disclosures
Celgene Corporation, A Bristol-myers Squibb Company	ABECMA	idecabtagene vicleucel	Injection	125736	11,261,281	2038-10-11	DrugPatentWatch analysis and company disclosures
Celgene Corporation, A Bristol-myers Squibb Company	ABECMA	idecabtagene vicleucel	Injection	125736	11,617,794	2033-03-19	DrugPatentWatch analysis and company disclosures
Celgene Corporation, A Bristol-myers Squibb Company	ABECMA	idecabtagene vicleucel	Injection	125736	11,623,989	2040-11-25	DrugPatentWatch analysis and company disclosures
Celgene Corporation, A Bristol-myers Squibb Company	ABECMA	idecabtagene vicleucel	Injection	125736	11,883,405	2038-05-31	DrugPatentWatch analysis and company disclosures

Similar Applicant Names

Companies are sometimes listed under multiple names.
This search can help find similar names.

• Celgene Corporation, A Bristol-myers Squibb Company